T
Taj For Doctors
Taj For DoctorsTaj Doctor
home

About Us

Taj Brands

Diseases Health Tips  HIV/AIDS News Contact Us

 
flick left flick upper right
menu upper

  All News
  Allergy
  Asthma
  Cardiology
  Clinical Research
  Critical Care
  Dentistry
  Dermatology
  Endocrinology
  Gastroenterology
  General
  Genetics / Biotech
  Men's Health
  Infectious Diseases
  Fitness/Lifestyle
  Nephrology
  Neurology
  Oncology/Haematology
  Ophthalmology
  Orthopaedics
  Otolaryngology
  Paediatrics
  Psychiatry
  Reproductive Health
  Respiratory Medicine
  Surgery
  Sex
  Urology
  Women's Health
menu lower
PRESS News back

The premier health and medical news on the Internet
Taj For Doctors.com offers accurate, readable and informative news reports every day.
Industry Briefing:: >> More Headlines
All Professional News:
Clinical::
o- ConjuChem stock plunges after patient death
Drug & Device Development::
o- Carrageenan blocks infection by human papilloma virus
o- Barr to develop test for amniotic fluid leakage
Industry::
o- UK pharma body reinstates Abbott, further review of conduct within six xxmonths
o- RESEARCH ALERT - Pacific Growth ups Forest Laboratories
o- Lundbeck shares climb after drug patent win in US
o- EResearchTechnology cuts Q2 rev view on clinical trial delays
o- Chemed expects Q2 earnings of $0.48/shr
o- Stada to bid 485 mln euros for Serbia's Hemofarm
o- Swiss drug firms to showcase healthy Q2 profits
o- Micrus to sell 1.27 million shares in offering
o- Schering in Alzheimer's diagnosis pact with Avid
o- RESEARCH ALERT - Jefferies ups Forest Laboratories: MarketWatch
o- RESEARCH ALERT - ING starts France's BioAlliance on "buy"
o- Swiss bourse reprimands SHL for "severe breach"
o- Medical firm Gyrus says H1 to meet expectations
o- Novartis says controls 75.4 pct of NeuTec shares
o- Jefferies ups Forest Laboratories
o- Magellan gets antitrust OK for Icore Healthcare
o- Kinetic Concepts shares rally before jury verdict
o- Alexion buys new plant to make blood disorder drug
o- ICD market could take longer to rebound: analysts
o- CollaGenex CEO eyes broad dermatology portfolio
o- United Surgical Partners' unit starts tender offer for notes
o- ANALYSIS-Amgen seen poised to rally on pipeline, valuation
o- Chemed shares slide after earnings warning
o- Lexapro patent win sends Forest shares surging
o- RESEARCH ALERT - WR Hambrecht starts Luna Innovations with "buy"
Legal::
o- US court upholds Forest Lexapro patent, shares jump
o- Merck wins Vioxx case in New Jersey
o- Belgian firm sues Nobel Biocare over patents 
Managed Care::
o- UK doctors to face regular checks, post-Shipman
o-LHC Group prices share offering at $19.25 a share
o-Rhoen Klinikum profit seen rising in Q2 
o-RESEARCH ALERT - Goldman Sachs upgrades Ramsay to "outperform"
Human Interest::
o- US pre-term births are up but fewer newborns die

  

Professional Development::
o- Transgene head Christophe Merieux dies
Regulatory::
o- NICE faces appeal storm over its rejection of drugs in early Alzheimer's
o- Nabi says FDA panel votes for hepatitis B vaccine
flick flick right
 
 
 
 
 
 

         Copyright 2004- 2006 TAJ Pharmaceuticals Limited. All Rights Reserved.

Site Requirements : Internet Explorer 5.0+ or Netscape 5.0+, Flash Player 5.0 & Real Player 8 Basic
To get in touch with us, call on 91-22-2637 4592, 91--22-2637 4593 or fax us at 91-22-2634 1274 

Terms and Conditions | Disclaimer | Privacy Policy | Sitemap | Feedback | FAQ